CD4 and neoplasm: Specifically, high-risk patients showed increased infiltration of malignant cells and fibroblasts but decreased infiltration of immune cells such as CD8+ T cells and CD4+ T cells, suggesting that DRGS may influence the tumor immune microenvironment in ESCC patients, thereby impacting their prognosis.